EUVIMEDEUVIMED entdecken
Crossref

Faecal Cytolysin is Associated With Worse Survival in Patients With Primary Sclerosing Cholangitis

Burcin Özdirik, Hilmar Berger, Fernanda Raya Tonetti, Noemí Cabré, Nicole Treichel, Thomas Clavel, Frank Tacke iD, Michael Sigal, Bernd Schnabl iD

Liver International · 2025-04 · 45 (4)

DOI: 10.1111/liv.16181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 14.03.2025. Verfasst von Burcin Özdirik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Feces, Enterococcus faecalis, Perforin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institutes of Healthy (NIH), Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Primary sclerosing cholangitis (PSC) is an immune‐related cholangiopathy without treatment options beyond liver transplantation. The gut–liver axis, especially the role of gut microbes, has emerged as a crucial pathway contributing to PSC pathogenesis. Recent research has revealed Enterococcus (E.) faecalis and its virulence factor cytolysin to increase mortality risk in patients with alcohol‐associated hepatitis. Thus, we studied the role of enterococci, particularly E. faecalis and its virulence factor genes cytolysin and gelatinase, in faecal samples from patients with PSC.

Methods

To assess the relevance of Enterococcus species, we performed 16S rRNA gene amplicon analysis in faecal samples from 60 patients with PSC. We validated our findings by qPCR of faecal microbial DNA in an extended cohort of 105 patients with PSC, 104 patients with inflammatory bowel disease (IBD) and 68 healthy subjects.

Results

High‐throughput 16S rRNA amplicon analysis revealed an increased relative abundance of enterococci in PSC patients compared with healthy controls and IBD patients, respectively, ( p < 0.0001). PSC patients with high enterococci abundance had a decreased probability of transplant‐free survival ( p = 0.028). E. faecalis and its virulence factors cytolysin and gelatinase were more abundant in patients with PSC. Higher faecal cytolysin was associated with lower overall survival ( p = 0.04), while survival was independent of gelatinase levels.

Conclusion

Our data highlight the association of E. faecalis and faecal cytolysin with lower survival in patients with PSC. These data should prompt further research into the pathogenic role of cytolysin‐positive E. faecalis , and to explore its role as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingFecesEnterococcus faecalisPerforinHumansMaleFemaleMiddle AgedAdultRNA, Ribosomal, 16SCase-Control StudiesInflammatory Bowel DiseasesGastrointestinal MicrobiomeLiver TransplantationAgedVirulence Factors

Stichwörter der Autor:innen

cytolysinenterococcigelatinaseprimary sclerosing cholangitis

Substanzen

RNA, Ribosomal, 16SPerforinVirulence Factors

Autor:innen und Institutionen

  • Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Functional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH Aachen, Aachen, Germany.
  • Department of Medicine, VA San Diego Healthcare System, San Diego, California, USA.

ORCID-Profile: Frank Tacke, Bernd Schnabl

Förderung

  • NIDDK NIH HHS
  • National Institutes of Healthy (NIH)
  • Deutsche Forschungsgemeinschaft
  • Biomedical Laboratory Research & Development Service of the VA Office of Research and Development
  • Office of Research and Development

Zitieren

APA

Özdirik, B., Berger, H., Tonetti, F. R., Cabré, N., Treichel, N., Clavel, T., Tacke, F., Sigal, M., & Schnabl, B. (2025). Faecal Cytolysin is Associated With Worse Survival in Patients With Primary Sclerosing Cholangitis. Liver International, 45(4). https://doi.org/10.1111/liv.16181

Vancouver

Özdirik B, Berger H, Tonetti FR, Cabré N, Treichel N, Clavel T, et al. Faecal Cytolysin is Associated With Worse Survival in Patients With Primary Sclerosing Cholangitis. Liver International. 2025;45(4). doi:10.1111/liv.16181

BibTeX
@article{zdirik2025,
  author = {Özdirik, Burcin and Berger, Hilmar and Tonetti, Fernanda Raya and Cabré, Noemí and Treichel, Nicole and Clavel, Thomas and Tacke, Frank and Sigal, Michael and Schnabl, Bernd},
  title = {Faecal Cytolysin is Associated With Worse Survival in Patients With Primary Sclerosing Cholangitis},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {4},
  doi = {10.1111/liv.16181}
}
Kostenlos starten →